221 related articles for article (PubMed ID: 27714851)
21. Monoclonal antibodies against interleukin 13 and interleukin 31RA in development for atopic dermatitis.
Hamann CR; Thyssen JP
J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S37-S42. PubMed ID: 29248521
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-31 and Pruritic Skin.
Furue M; Furue M
J Clin Med; 2021 Apr; 10(9):. PubMed ID: 33924978
[TBL] [Abstract][Full Text] [Related]
23. Blockage of the IL-31 Pathway as a Potential Target Therapy for Atopic Dermatitis.
Orfali RL; Aoki V
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839897
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous T-cell Lymphoma and Pruritus: The Expression of IL-31 and its Receptors in the Skin.
Nattkemper LA; Martinez-Escala ME; Gelman AB; Singer EM; Rook AH; Guitart J; Yosipovitch G
Acta Derm Venereol; 2016 Nov; 96(7):894-898. PubMed ID: 27001482
[TBL] [Abstract][Full Text] [Related]
25. Involvement of thromboxane A
Andoh T; Li S; Uta D
Pharmacol Rep; 2018 Apr; 70(2):251-257. PubMed ID: 29477033
[TBL] [Abstract][Full Text] [Related]
26. Oncostatin M suppresses
Suehiro M; Numata T; Saito R; Yanagida N; Ishikawa C; Uchida K; Kawaguchi T; Yanase Y; Ishiuji Y; McGrath J; Tanaka A
Front Immunol; 2023; 14():1251031. PubMed ID: 38035099
[TBL] [Abstract][Full Text] [Related]
27. Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis.
Ruzicka T; Hanifin JM; Furue M; Pulka G; Mlynarczyk I; Wollenberg A; Galus R; Etoh T; Mihara R; Yoshida H; Stewart J; Kabashima K;
N Engl J Med; 2017 Mar; 376(9):826-835. PubMed ID: 28249150
[TBL] [Abstract][Full Text] [Related]
28. Barbiturates enhance itch-associated scratching in atopic dermatitis mice: A possible clue to understanding nocturnal pruritus in atopic dermatitis.
Fujii M; Takeuchi K; Umehara Y; Takeuchi M; Nakayama T; Ohgami S; Asano E; Nabe T; Ohya S
Eur J Pharmacol; 2018 Oct; 836():57-66. PubMed ID: 30125561
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-31 pathway and its role in atopic dermatitis: a systematic review.
Saleem MD; Oussedik E; D'Amber V; Feldman SR
J Dermatolog Treat; 2017 Nov; 28(7):591-599. PubMed ID: 28145790
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis.
Gonzales AJ; Humphrey WR; Messamore JE; Fleck TJ; Fici GJ; Shelly JA; Teel JF; Bammert GF; Dunham SA; Fuller TE; McCall RB
Vet Dermatol; 2013 Feb; 24(1):48-53.e11-2. PubMed ID: 23331679
[TBL] [Abstract][Full Text] [Related]
31. Involvement of IL-31 on scratching behavior in NC/Nga mice with atopic-like dermatitis.
Takaoka A; Arai I; Sugimoto M; Honma Y; Futaki N; Nakamura A; Nakaike S
Exp Dermatol; 2006 Mar; 15(3):161-7. PubMed ID: 16480423
[TBL] [Abstract][Full Text] [Related]
32. Ethanol aggravates itch-related scratching in hairless mice developing atopic dermatitis.
Fujii M; Nakamura T; Fukuno S; Mizutani N; Nabe T; Kohno S
Eur J Pharmacol; 2009 Jun; 611(1-3):92-9. PubMed ID: 19344707
[TBL] [Abstract][Full Text] [Related]
33. IL-31 expression by inflammatory cells is preferentially elevated in atopic dermatitis.
Nobbe S; Dziunycz P; Mühleisen B; Bilsborough J; Dillon SR; French LE; Hofbauer GF
Acta Derm Venereol; 2012 Jan; 92(1):24-8. PubMed ID: 22041865
[TBL] [Abstract][Full Text] [Related]
34. Vital role of the itch-scratch response in development of spontaneous dermatitis in NC/Nga mice.
Mihara K; Kuratani K; Matsui T; Nakamura M; Yokota K
Br J Dermatol; 2004 Aug; 151(2):335-45. PubMed ID: 15327540
[TBL] [Abstract][Full Text] [Related]
35. The IL-31/IL-31 receptor axis: general features and role in tumor microenvironment.
Ferretti E; Corcione A; Pistoia V
J Leukoc Biol; 2017 Sep; 102(3):711-717. PubMed ID: 28408397
[TBL] [Abstract][Full Text] [Related]
36. Scratching damages tight junctions through the Akt-claudin 1 axis in atopic dermatitis.
Hu XQ; Tang Y; Ju Y; Zhang XY; Yan JJ; Wang CM; Yang Y; Zhu C; Tang ZX; Zhou Y; Yu G
Clin Exp Dermatol; 2021 Jan; 46(1):74-81. PubMed ID: 32668051
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-31 as a Clinical Target for Pruritus Treatment.
Kabashima K; Irie H
Front Med (Lausanne); 2021; 8():638325. PubMed ID: 33644103
[TBL] [Abstract][Full Text] [Related]
38. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis.
Bilsborough J; Leung DY; Maurer M; Howell M; Boguniewicz M; Yao L; Storey H; LeCiel C; Harder B; Gross JA
J Allergy Clin Immunol; 2006 Feb; 117(2):418-25. PubMed ID: 16461143
[TBL] [Abstract][Full Text] [Related]
39. IL-23 modulates histamine-evoked itch and responses of pruriceptors in mice.
Pavlenko D; Funahashi H; Sakai K; Hashimoto T; Lozada T; Yosipovitch G; Akiyama T
Exp Dermatol; 2020 Dec; 29(12):1209-1215. PubMed ID: 33010057
[TBL] [Abstract][Full Text] [Related]
40. Itch intensity in prurigo nodularis is closely related to dermal interleukin-31, oncostatin M, IL-31 receptor alpha and oncostatin M receptor beta.
Hashimoto T; Nattkemper LA; Kim HS; Kursewicz CD; Fowler E; Shah SM; Nanda S; Fayne RA; Paolini JF; Romanelli P; Yosipovitch G
Exp Dermatol; 2021 Jun; 30(6):804-810. PubMed ID: 33428793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
